NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,515,000 | -54.3% | 16,954 | -54.1% | 0.17% | -23.5% |
| Q4 2020 | $3,312,000 | +33.9% | 36,907 | +21.4% | 0.22% | +58.4% |
| Q3 2020 | $2,473,000 | +135.3% | 30,400 | +62.0% | 0.14% | +117.5% |
| Q2 2020 | $1,051,000 | +26175.0% | 18,770 | +1777.0% | 0.06% | +6200.0% |
| Q1 2020 | $4,000 | -69.2% | 1,000 | -78.7% | 0.00% | -93.3% |
| Q4 2018 | $13,000 | +333.3% | 4,700 | +176.5% | 0.02% | +650.0% |
| Q4 2017 | $3,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |